Skip to content

SPRING PHARMACEUTICAL GROUP, INC.: filings

Every SPRING PHARMACEUTICAL GROUP, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 41 filings, each linked to its SEC index.

Filing record ends 2019-02-14

The latest filing in this captured record is a 10-Q filed 2019-02-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. SPRING PHARMACEUTICAL GROUP, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2019-02-14fiscal Q3 201936960001096906-19-000070
10-Q2018-11-13fiscal Q2 201936960001096906-18-000632
10-Q2018-08-14fiscal Q1 201936740001096906-18-000485
10-K2018-06-29fiscal FY 201836740001096906-18-000372
10-Q2018-02-14fiscal Q3 201834920001096906-18-000105
10-Q2017-11-14fiscal Q2 201833890001096906-17-000731
10-Q2017-08-14fiscal Q1 201833680001096906-17-000528
10-K2017-06-29fiscal FY 201733680001096906-17-000447
10-Q2017-02-13fiscal Q3 201730820001096906-17-000084
10-Q2016-11-14fiscal Q2 201729780001096906-16-002056
10-Q2016-08-15fiscal Q1 201729590001096906-16-001828
10-K2016-06-29fiscal FY 201629580001096906-16-001729
10-Q2016-02-16fiscal Q3 201630810001096906-16-001393
10-Q2015-11-16fiscal Q2 201630810001096906-15-001180
10-Q2015-08-14fiscal Q1 201629590001096906-15-000918
10-K2015-07-13fiscal FY 201530610001096906-15-000749
10-Q2015-02-17fiscal Q3 201528800001144204-15-009643
10-Q2014-11-14fiscal Q2 201528780001144204-14-068359
10-Q2014-08-14fiscal Q1 201528590001144204-14-049803
10-K2014-06-30fiscal FY 201429600001144204-14-040490
10-Q2014-02-19fiscal Q3 201328800001144204-14-010578
10-Q2013-11-14fiscal Q2 201331840001144204-13-061538
10-Q2013-08-13fiscal Q1 201331640001144204-13-044975
10-K2013-07-01fiscal FY 201232650001144204-13-037466
10-Q2013-02-14fiscal Q3 201231910001144204-13-008541
10-K/A2012-11-23fiscal FY 201129560001144204-12-064613
10-Q/A2012-11-23fiscal Q1 201233620001144204-12-064600
10-Q2012-11-14fiscal Q2 201231850001144204-12-062227
10-Q/A2012-09-12fiscal Q1 201233620001144204-12-050742
10-K2012-07-11fiscal FY 201129550001144204-12-038963
10-Q/A2012-07-06fiscal Q2 201125670001144204-12-038485
10-Q/A2012-07-06fiscal Q3 201125720001144204-12-038468
10-K/A2012-07-06fiscal FY 201028570001144204-12-038465
10-Q/A2012-07-06fiscal Q1 201128560001144204-12-038407
10-Q/A2012-06-13fiscal Q3 201126740001144204-12-034574
10-Q/A2012-06-12fiscal Q2 201125670001144204-12-034391
10-Q/A2012-06-12fiscal Q1 201128560001144204-12-034389
10-K/A2012-06-08fiscal FY 201028570001144204-12-033955
10-Q2012-02-16fiscal Q3 201126720001144204-12-009589
10-Q2011-11-14fiscal Q2 201125670001144204-11-063253
10-Q/A2011-09-12fiscal Q1 201128610001144204-11-052391

Inspect the source

Entity
SPRING PHARMACEUTICAL GROUP, INC. / CIK 0000847464
Captured
SEC response SHA-256
21fd63bfa4a441f5dd22dbcc8093e88a40c5d63950c8b6833c77a7b4245f4dc7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000847464.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))